Last $7.44 USD
Change Today +0.12 / 1.64%
Volume 1.6M
MACK On Other Exchanges
Symbol
Exchange
Frankfurt
As of 5:20 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for merrimack pharmaceuticals in (MACK)

Year over year, Merrimack Pharmaceuticals, Inc. has seen net income shrink from a loss of $91.3M USD to an even larger loss of $130.9M USD despite relatively flat revenues. A key factor has been an increase in the percentage of sales devoted to the cost of goods sold from 257.27% to 306.22%.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
4 Year
Trend
Revenues20.334.248.947.8
TOTAL REVENUES20.334.248.947.8
Cost of Goods Sold58.3100.6125.9146.3
GROSS PROFIT-38.0-66.4-76.9-98.5
Selling General & Admin Expenses, Total11.414.515.821.2
OTHER OPERATING EXPENSES, TOTAL11.414.515.821.2
OPERATING INCOME-49.4-80.9-92.7-119.7
Interest Expense-3.70.0-0.6-10.9
Interest and Investment Income0.10.10.20.2
NET INTEREST EXPENSE-3.70.0-0.4-10.8
Other Non-Operating Income (Expenses)2.71.21.40.6
EBT, EXCLUDING UNUSUAL ITEMS-50.3-79.7-91.8-129.9
Other Unusual Items, Total0.2-----0.8
Other Unusual Items0.2------
EBT, INCLUDING UNUSUAL ITEMS-50.2-79.7-91.8-130.7
Minority Interest in Earnings0.10.50.5-0.2
Earnings from Continuing Operations-50.2-79.7-91.8-130.7
NET INCOME-50.1-79.2-91.3-130.9
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-61.3-87.0-93.4-130.9
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-61.3-87.0-93.4-130.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MACK:US $7.44 USD +0.12

MACK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MACK.
View Industry Companies
 

Industry Analysis

MACK

Industry Average

Valuation MACK Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRIMACK PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.